{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:08:43Z","timestamp":1764601723884,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007438","name":"Familien Hede Nielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novartis Healthcare"},{"name":"The Vissing Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11695-020-04387-6","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T09:04:04Z","timestamp":1578301444000},"page":"1038-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-7504","authenticated-orcid":false,"given":"Caroline C.","family":"\u00d8hrstr\u00f8m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorte","family":"Worm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urd Lynge","family":"Kielgast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Juul","family":"Holst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorte L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"4387_CR1","unstructured":"Estimate of Bariatric Surgery Numbers, 2011\u20132017 [Internet]. American Society for Metabolic and Bariatric Surgery. [cited 2018 Oct 18]. Available from: https:\/\/asmbs.org\/resources\/estimate-of-bariatric-surgery-numbers"},{"key":"4387_CR2","doi-asserted-by":"crossref","unstructured":"Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014 Feb;2(2):152\u201364.","DOI":"10.1016\/S2213-8587(13)70218-3"},{"key":"4387_CR3","doi-asserted-by":"crossref","unstructured":"J\u00f8rgensen NB, Jacobsen SH, Dirksen C, Bojsen-M\u00f8ller KN, Naver L, Hvolris L, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E122\u2013131.","DOI":"10.1152\/ajpendo.00073.2012"},{"key":"4387_CR4","doi-asserted-by":"crossref","unstructured":"Emous M, Wolffenbuttel BHR, Tott\u00e9 E, van Beek AP. The short- to mid-term symptom prevalence of dumping syndrome after primary gastric-bypass surgery and its impact on health-related quality of life. Surg Obes Relat Dis. 2017 Sep;13(9):1489\u2013500.","DOI":"10.1016\/j.soard.2017.04.028"},{"key":"4387_CR5","doi-asserted-by":"crossref","unstructured":"Goldfine AB, Patti ME. How common is hypoglycemia after gastric bypass? Obesity. 2016 Jun 1;24(6):1210\u20131.","DOI":"10.1002\/oby.21520"},{"key":"4387_CR6","doi-asserted-by":"crossref","unstructured":"Nielsen JB, Pedersen AM, Gribsholt SB, Svensson E, Richelsen B. Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016 Oct;12(8):1562\u20138.","DOI":"10.1016\/j.soard.2016.04.017"},{"key":"4387_CR7","doi-asserted-by":"crossref","unstructured":"Wijma RB, Emous M, van den Broek M, Laskewitz A, Kobold ACM, van Beek AP. Prevalence and pathophysiology of early dumping in patients after primary Roux-en-Y gastric bypass during a mixed-meal tolerance test. Surg Obes Relat Dis. 2019;15(1):73\u201381.","DOI":"10.1016\/j.soard.2018.10.004"},{"key":"4387_CR8","doi-asserted-by":"crossref","unstructured":"Tack J, Arts J, Caenepeel P, De Wulf D, Bisschops R. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nature Reviews Gastroenterology &#38; Hepatology. 2009 Oct;6(10):583\u201390.","DOI":"10.1038\/nrgastro.2009.148"},{"key":"4387_CR9","doi-asserted-by":"crossref","unstructured":"van der Kleij FG, Vecht J, Lamers CB, Masclee AA. Diagnostic value of dumping provocation in patients after gastric surgery. Scand J Gastroenterol. 1996 Dec;31(12):1162\u20136.","DOI":"10.3109\/00365529609036905"},{"key":"4387_CR10","doi-asserted-by":"crossref","unstructured":"Mehagnoul-Schipper DJ, Lenders JW, Willemsen JJ, Hopman WP. Sympathoadrenal activation and the dumping syndrome after gastric surgery. Clin Auton Res. 2000 Oct;10(5):301\u20138.","DOI":"10.1007\/BF02281113"},{"key":"4387_CR11","doi-asserted-by":"crossref","unstructured":"Gebhard B, Holst JJ, Biegelmayer C, Miholic J. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci. 2001 Sep;46(9):1915\u201323.","DOI":"10.1023\/A:1010635131228"},{"key":"4387_CR12","doi-asserted-by":"crossref","unstructured":"Salehi M, Vella A, McLaughlin T, Patti M-E. Hypoglycemia After Gastric bypass surgery: current concepts and controversies. J Clin Endocrinol Metab. 2018 01;103(8):2815\u201326.","DOI":"10.1210\/jc.2018-00528"},{"key":"4387_CR13","doi-asserted-by":"crossref","unstructured":"Tharakan G, Behary P, Wewer Albrechtsen NJ, Chahal H, Kenkre J, Miras AD, et al. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass. Eur J Endocrinol. 2017 Dec;177(6):455\u201364.","DOI":"10.1530\/EJE-17-0446"},{"key":"4387_CR14","doi-asserted-by":"crossref","unstructured":"Laurenius A, Werling M, Le Roux CW, F\u00e4ndriks L, Olbers T. More symptoms but similar blood glucose curve after oral carbohydrate provocation in patients with a history of hypoglycemia-like symptoms compared to asymptomatic patients after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014 Dec;10(6):1047\u201354.","DOI":"10.1016\/j.soard.2014.04.007"},{"key":"4387_CR15","doi-asserted-by":"crossref","unstructured":"Abrahamsson N, Ed\u00e9n Engstr\u00f6m B, Sundbom M, Karlsson FA. Hypoglycemia in everyday life after gastric bypass and duodenal switch. Eur J Endocrinol. 2015 Jul;173(1):91\u2013100.","DOI":"10.1530\/EJE-14-0821"},{"key":"4387_CR16","doi-asserted-by":"crossref","unstructured":"Valderas JP, Ahuad J, Rubio L, Escalona M, Pollak F, Maiz A. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels. Obesity Surgery. 2012 Apr;22(4):582\u20136.","DOI":"10.1007\/s11695-011-0581-0"},{"key":"4387_CR17","doi-asserted-by":"crossref","unstructured":"Moreira RO, Moreira RBM, Machado NAM, Gon\u00e7alves TB, Coutinho WF. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obesity Surgery. 2008 Dec;18(12):1618\u201321.","DOI":"10.1007\/s11695-008-9569-9"},{"key":"4387_CR18","doi-asserted-by":"crossref","unstructured":"Abrahamsson N, Engstrom BE, Sundbom M, Karlsson FA. GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication? European Journal of Endocrinology. 2013 Oct 21;169(6):885\u20139.","DOI":"10.1530\/EJE-13-0504"},{"key":"4387_CR19","doi-asserted-by":"crossref","unstructured":"Deloose E, Bisschops R, Holvoet L, Arts J, De Wulf D, Caenepeel P, et al. A pilot study of the effects of the somatostatin analog pasireotide in postoperative dumping syndrome. Neurogastroenterol Motil. 2014 Jun 1;26(6):803\u20139.","DOI":"10.1111\/nmo.12333"},{"key":"4387_CR20","doi-asserted-by":"crossref","unstructured":"\u00d8hrstr\u00f8m CC, Worm D, H\u00f8jager A, Andersen D, Holst JJ, Kielgast UL, et al. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide. Diabetes Obes Metab. 2019 Sep;21(9):2142\u201351.","DOI":"10.1111\/dom.13796"},{"key":"4387_CR21","doi-asserted-by":"crossref","unstructured":"Vecht J, van Oostayen JA, Lamers CB, Masclee AA. Measurement of superior mesenteric artery flow by means of Doppler ultrasound in early dumping syndrome. Am J Gastroenterol. 1998 Dec;93(12):2380\u20134.","DOI":"10.1111\/j.1572-0241.1998.00691.x"},{"key":"4387_CR22","doi-asserted-by":"crossref","unstructured":"Nguyen NQ, Debreceni TL, Burgstad CM, Wishart JM, Bellon M, Rayner CK, et al. Effects of posture and meal volume on gastric emptying, intestinal transit, oral glucose tolerance, blood pressure and gastrointestinal symptoms after Roux-en-Y gastric bypass. OBES SURG. 2015 Aug 1;25(8):1392\u2013400.","DOI":"10.1007\/s11695-014-1531-4"},{"key":"4387_CR23","doi-asserted-by":"crossref","unstructured":"Dirksen C, J\u00f8rgensen NB, Bojsen-M\u00f8ller KN, Kielgast U, Jacobsen SH, Clausen TR, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (Lond). 2013 Nov;37(11):1452\u20139.","DOI":"10.1038\/ijo.2013.15"},{"key":"4387_CR24","doi-asserted-by":"crossref","unstructured":"Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. The Journal of Clinical Endocrinology & Metabolism. 2007 Dec;92(12):4678\u201385.","DOI":"10.1210\/jc.2007-0918"},{"key":"4387_CR25","doi-asserted-by":"crossref","unstructured":"Vecht J, Winter M, P C, Lamers CBHW, Masclee A a. M. Acute vasodilatation in early dumping syndrome. Netherlands Journal of Medicine. 1996;1(48):A28\u20139.","DOI":"10.1016\/0300-2977(96)89620-3"},{"key":"4387_CR26","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Mori T, Tsuchihashi H, Akabori H, Naito H, Tani T. A possible role of GLP-1 in the pathophysiology of early dumping syndrome. Digestive Diseases and Sciences. 2005 Dec;50(12):2263\u20137.","DOI":"10.1007\/s10620-005-3046-2"},{"key":"4387_CR27","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest. 2002 Jul;110(1):43\u201352.","DOI":"10.1172\/JCI0215595"},{"key":"4387_CR28","doi-asserted-by":"crossref","unstructured":"Toft-Nielsen M, Madsbad S, Holst JJ. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia. 1998 Oct;41(10):1180\u20136.","DOI":"10.1007\/s001250051049"},{"key":"4387_CR29","doi-asserted-by":"crossref","unstructured":"Ritzel R, \u00d8rskov C, Holst JJ, Nauck MA. Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7\u201336 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships. Diabetologia. 1995 Jun 1;38(6):720\u20135.","DOI":"10.1007\/s001250050344"},{"key":"4387_CR30","doi-asserted-by":"crossref","unstructured":"Hj\u00f8llund KR, Deacon CF, Holst JJ. Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs. Diabetologia. 2011 Aug 1;54(8):2206\u20138.","DOI":"10.1007\/s00125-011-2168-7"},{"key":"4387_CR31","doi-asserted-by":"crossref","unstructured":"Cadegiani FA, Silva OS. Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients. Diabetes Metab Syndr Obes. 2016;9:443\u20136.","DOI":"10.2147\/DMSO.S123244"},{"key":"4387_CR32","doi-asserted-by":"crossref","unstructured":"Dobre D, Borer JS, Fox K, Swedberg K, Adams KF, Cleland JGF, et al. Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. European Journal of Heart Failure. 2014;16(1):76\u201385.","DOI":"10.1093\/eurjhf\/hft129"},{"key":"4387_CR33","doi-asserted-by":"crossref","unstructured":"Lorenz M, Lawson F, Owens D, Raccah D, Roy-Duval C, Lehmann A, et al. Differential effects of glucagon-like peptide-1 receptor agonists on heart rate. Cardiovasc Diabetol. 2017 13;16(1):6.","DOI":"10.1186\/s12933-016-0490-6"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-04387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-020-04387-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-04387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:09:17Z","timestamp":1609805357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-020-04387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1007\/s11695-020-04387-6","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"type":"print","value":"0960-8923"},{"type":"electronic","value":"1708-0428"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"6 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Jens Juul Holst has served on advisory boards for Novo Nordisk and received speaker fees from MSD. All the other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}